Beyond Weight Loss: Eli Lilly’s Brenipatide Targets the Brain to Tackle Addiction and Mental Health
In a bold strategic pivot that underscores the pharmaceutical industry's growing fascination with incretin-based therapies, Eli Lilly and Company has...
